J Med Microbiol International Journal of Systematic and Evolutionary Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewin, C. S.
Right arrow Articles by Smith, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewin, C. S.
Right arrow Articles by Smith, J. T.
Agricola
Right arrow Articles by Lewin, C. S.
Right arrow Articles by Smith, J. T.

The Journal of Medical Microbiology, Vol 29, Issue 2 139-144, Copyright © 1989 by Society for General Microbiology


JOURNAL ARTICLE

4-quinolones and the SOS response

C. S. Lewin, B. M. Howard, N. T. Ratcliffe and J. T. Smith
Department of Pharmaceutics, School of Pharmacy, London University, Brunswick Square.

The SOS DNA repair system is induced in bacteria treated with 4-quinolones. However, whether the response exacerbates or repairs the damage caused by these drugs is still unclear. The recA13 and the recB21 mutations impair recombination repair and render bacteria unable to induce the SOS response when treated with nalidixic acid or other agents that affect DNA synthesis. However, UV treatment induces the SOS response in recB21 mutants but not in recA13 mutants. Both these mutants are hypersensitive to nalidixic acid and, therefore, either recombination repair or SOS repair would appear to repair DNA damage caused by the drug. However, since the lexA3 mutation (which also renders bacteria incapable of inducing the SOS response without affecting recombination repair) had no effect on the susceptibility of bacteria to nalidixic acid, the SOS response neither contributes to nor repairs DNA damage caused by the drug. Consequently, it would seem that the hypersensitivity of the recA13 and recB21 mutants to nalidixic acid is due to their deficiency in recombination repair. This view was confirmed by testing a recA430 mutant that is recombination-repair proficient but SOS repair-deficient and finding it to be no more sensitive to nalidixic acid than its parent. Thus it would appear that, although induced by nalidixic acid treatment, the SOS DNA repair system does not play any role in bacterial responses to the damage caused by the drug. In contrast, the recombination repair system does repair damage caused by nalidixic acid.


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
J. R. Pohlhaus, D. T. Long, E. O'Reilly, and K. N. Kreuzer
The {varepsilon} Subunit of DNA Polymerase III Is Involved in the Nalidixic Acid-Induced SOS Response in Escherichia coli
J. Bacteriol., August 1, 2008; 190(15): 5239 - 5247.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
K. Drlica, M. Malik, R. J. Kerns, and X. Zhao
Quinolone-Mediated Bacterial Death
Antimicrob. Agents Chemother., February 1, 2008; 52(2): 385 - 392.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Sabourin, J. L. Nitiss, K. C. Nitiss, K. Tatebayashi, H. Ikeda, and N. Osheroff
Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks
Nucleic Acids Res., August 1, 2003; 31(15): 4373 - 4384.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
B. A. Stohr and K. N. Kreuzer
Repair of Topoisomerase-Mediated DNA Damage in Bacteriophage T4
Genetics, May 1, 2001; 158(1): 19 - 28.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
H. J. Wickens, R. J. Pinney, D. J. Mason, and V. A. Gant
Flow Cytometric Investigation of Filamentation, Membrane Patency, and Membrane Potential in Escherichia coli following Ciprofloxacin Exposure
Antimicrob. Agents Chemother., March 1, 2000; 44(3): 682 - 687.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1989 Society for General Microbiology.